• Home
  • Patient Portal
  • OUR TEAM
    • Therapists
    • ADHD Coaching
    • Mental Health GPs
    • Pediatrician
    • Psychiatrists
    • Client Support Team
    • FAQs
  • Conditions We Treat
    • Mood Disorders
    • Esketamine
    • Psychosis
    • ADHD & Autism
    • Anxiety and Trauma
    • Child and Adolescent
    • Neuropsychology
    • Medicolegal Services
  • Events
  • Professional Supervision
  • Resources & Blog
    • Resources
    • Think/See/Change
  • Contact Us
    • Contact Us
  • More
    • Home
    • Patient Portal
    • OUR TEAM
      • Therapists
      • ADHD Coaching
      • Mental Health GPs
      • Pediatrician
      • Psychiatrists
      • Client Support Team
      • FAQs
    • Conditions We Treat
      • Mood Disorders
      • Esketamine
      • Psychosis
      • ADHD & Autism
      • Anxiety and Trauma
      • Child and Adolescent
      • Neuropsychology
      • Medicolegal Services
    • Events
    • Professional Supervision
    • Resources & Blog
      • Resources
      • Think/See/Change
    • Contact Us
      • Contact Us
  • Home
  • Patient Portal
  • OUR TEAM
    • Therapists
    • ADHD Coaching
    • Mental Health GPs
    • Pediatrician
    • Psychiatrists
    • Client Support Team
    • FAQs
  • Conditions We Treat
    • Mood Disorders
    • Esketamine
    • Psychosis
    • ADHD & Autism
    • Anxiety and Trauma
    • Child and Adolescent
    • Neuropsychology
    • Medicolegal Services
  • Events
  • Professional Supervision
  • Resources & Blog
    • Resources
    • Think/See/Change
  • Contact Us
    • Contact Us

Hope for Depression

What is Esketamine (Spravato)?

Esketamine (Spravato) is Therapeutic Goods Administration (TGA) approved treatment for Treatment Resistant Depression which is defined as depression that persists despite adequate trials of two or more antidepressants.


Spravato is a nasal spray form of ketamine and has been shown to be safe and effective in the treatment of severe depression. However, it is a restricted medication and can only be delivered at certified treatment centers, like Mindsight Clinic. As of 1 May 2025, Spravato was PBS listed and now subsidised for patients who meet relevant criteria. 


If you think this treatment might be suitable for you, please discuss this with your treating psychiatrist or GP. 


*Esketamine can only be accessed with a relevant psychiatrist referral. If you do not have a treating psychiatrist, you will need to discuss this with your GP

To find out more about Spravato, please download the patient guide here:

Spravato Patient Guide (pdf)

Download

Mindsight Clinic Esketamine referral form for clinicians

Please submit this referral form if you would like to refer a patient for an assessment for Esketamine treatment

REFERRAL FOR ESKETAMINE THERAPY (pdf)

Download

Mindsight Clinic

Suite 5/924 Pacific Highway, Gordon New South Wales 2072, Australia

02 9157 9022

(c) Mindsight Clinic 2024

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept